Stuart Miles / Shutterstock.com
12 December 2019Big PharmaSaman Javed
New USMCA agreement scraps ten-year marketing exclusivity provision
The US, Canada and Mexico have signed a new, finalised trade agreement to replace the old North American Free Trade Agreement.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Big Pharma
3 December 2019 The Trump administration is considering shortening the period that big pharma companies’ biologic drugs are protected by marketing exclusivity from biosimilar competition.
Editor's picks
Editor's picks
Big Pharma
3 December 2019 The Trump administration is considering shortening the period that big pharma companies’ biologic drugs are protected by marketing exclusivity from biosimilar competition.
Big Pharma
3 December 2019 The Trump administration is considering shortening the period that big pharma companies’ biologic drugs are protected by marketing exclusivity from biosimilar competition.